RT Journal Article
SR Electronic
T1 Geospatial characterizing of Under-Five Mortality in Alexandria, Egypt
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.24.21255886
DO 10.1101/2021.04.24.21255886
A1 Hassan, Mahmoud Adel
A1 Ramadan, Ahmed
A1 Tahoun, Mohamed Mostafa
A1 Omran, Abdel Rahman
A1 Ebrahim Ali, Shaimaa Gad EL Karim
A1 Khedr Esmail, Ola Fahmy
A1 Adel Elrewany, Ehab Mohamed
A1 Ahmed El-Meligy, Passent Ehab El-din
A1 Elzayat, Amira Mahmoud
A1 el Malawany, Dina Hussein
A1 Mahboob, Amira Saad
A1 Eldewiki, Mohamed Kamal
A1 Abdellatif Hammouda, Esraa Abdellatif Mohamed
A1 Ghazy, Ramy Mohamed
YR 2021
UL http://medrxiv.org/content/early/2021/04/26/2021.04.24.21255886.abstract
AB This study aimed to identify geo-spatial pattern of under-five mortality (U5M) in Alexandria and its key determinants. We analyzed the geospatial distribution of 3064 deaths registered at 24 health offices reported from January 2018 to June 2019. The localities of Alexandria city were clustered into high and low incidence areas. Neonates represented 58.7% of U5M, while post-neonates and children were 31.1%, 10.2% respectively. Male deaths were significantly higher (P=0.036). The main leading causes of U5M were prematurity (28.32%), pneumonia (11.01%), cardiac arrest (10.57%), congenital malformation (9.95%), and childhood cardiovascular diseases (9.20%). Spatial distribution of U5M (including the most common three causes) tend to be clustered in western parts of Alexandria (El Hawaria, Bahig, Hamlis and Ketaa Maryiut). Another 9 clusters are at risk of being hotspots. Illiteracy, divorce, and poor locality characteristics (household size, population density, and access to water supply and sanitation), were statistically significant predictors of U5M.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fund was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical clearance was sought and approved from the Ethics Committee of High Institute of Public Health, Alexandria UniversityAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available upon request